Cargando…
Sweat chloride assay by inductively coupled plasma mass spectrometry: a confirmation test for cystic fibrosis diagnosis
The current guidelines for sweat chloride analysis identify the procedures for sweat collection, but not for chloride assay, which is usually performed by methods originally not aiming at the low concentrations of chloride found in sweat. To overcome this limitation, we set up, characterized, and ad...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7495987/ https://www.ncbi.nlm.nih.gov/pubmed/32691087 http://dx.doi.org/10.1007/s00216-020-02821-3 |
_version_ | 1783582998052995072 |
---|---|
author | Marvelli, Antonella Campi, Beatrice Mergni, Gianfranco Di Cicco, Maria Elisa Turini, Paola Scardina, Paolo Zucchi, Riccardo Pifferi, Massimo Taccetti, Giovanni Paolicchi, Aldo la Marca, Giancarlo Saba, Alessandro |
author_facet | Marvelli, Antonella Campi, Beatrice Mergni, Gianfranco Di Cicco, Maria Elisa Turini, Paola Scardina, Paolo Zucchi, Riccardo Pifferi, Massimo Taccetti, Giovanni Paolicchi, Aldo la Marca, Giancarlo Saba, Alessandro |
author_sort | Marvelli, Antonella |
collection | PubMed |
description | The current guidelines for sweat chloride analysis identify the procedures for sweat collection, but not for chloride assay, which is usually performed by methods originally not aiming at the low concentrations of chloride found in sweat. To overcome this limitation, we set up, characterized, and adopted an original inductively coupled plasma mass spectrometry (ICP-MS) method for sweat chloride determination, which was designed for its easy use in a clinical laboratory. The method was linear in the range 8.5E−3 to 272.0E−3 mM, precision exhibited a relative standard deviation < 6%, and accuracy was in the range 99.7–103.8%. Limit of blank, limit of detection, and limit of quantitation were 2.1 mM, 3.2 mM, and 7.0 mM, respectively, which correspond to real concentrations injected into the mass spectrometer of 3.9E−3 mM for LOD and 8.5E−3 mM for LOQ. At first, the method was tested on 50 healthy volunteers who exhibited a mean chloride concentration of 15.7 mM (25–75th percentile 10.1–19.3 mM, range 2.8–37.4 mM); then, it was used to investigate two patients with suspected cystic fibrosis, who exhibited sweat chloride values of 65.6 mM and 81.2 mM, respectively. Moreover, the method was cross-validated by assaying 50 samples with chloride concentration values in the range 10–131 mM, by both ICP-MS and coulometric titration, which is the technology officially used in Tuscany for cystic fibrosis newborn screening. The reference analytical performances and the relatively low cost of ICP-MS, accompanied by the advantageous cost of a single sweat chloride assay, make this technology the best candidate to provide a top reference method for the quantification of chloride in sweat. The method that we propose was optimized and validated for sweat samples ≥ 75 mg, which is the minimum amount requested by the international protocols. However, the method sensitivity and, in addition, the possibility to reduce the sample dilution factor, make possible the quantification of chloride even in samples weighting < 75 mg that are discarded according to the current guidelines. [Figure: see text] |
format | Online Article Text |
id | pubmed-7495987 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-74959872020-09-29 Sweat chloride assay by inductively coupled plasma mass spectrometry: a confirmation test for cystic fibrosis diagnosis Marvelli, Antonella Campi, Beatrice Mergni, Gianfranco Di Cicco, Maria Elisa Turini, Paola Scardina, Paolo Zucchi, Riccardo Pifferi, Massimo Taccetti, Giovanni Paolicchi, Aldo la Marca, Giancarlo Saba, Alessandro Anal Bioanal Chem Research Paper The current guidelines for sweat chloride analysis identify the procedures for sweat collection, but not for chloride assay, which is usually performed by methods originally not aiming at the low concentrations of chloride found in sweat. To overcome this limitation, we set up, characterized, and adopted an original inductively coupled plasma mass spectrometry (ICP-MS) method for sweat chloride determination, which was designed for its easy use in a clinical laboratory. The method was linear in the range 8.5E−3 to 272.0E−3 mM, precision exhibited a relative standard deviation < 6%, and accuracy was in the range 99.7–103.8%. Limit of blank, limit of detection, and limit of quantitation were 2.1 mM, 3.2 mM, and 7.0 mM, respectively, which correspond to real concentrations injected into the mass spectrometer of 3.9E−3 mM for LOD and 8.5E−3 mM for LOQ. At first, the method was tested on 50 healthy volunteers who exhibited a mean chloride concentration of 15.7 mM (25–75th percentile 10.1–19.3 mM, range 2.8–37.4 mM); then, it was used to investigate two patients with suspected cystic fibrosis, who exhibited sweat chloride values of 65.6 mM and 81.2 mM, respectively. Moreover, the method was cross-validated by assaying 50 samples with chloride concentration values in the range 10–131 mM, by both ICP-MS and coulometric titration, which is the technology officially used in Tuscany for cystic fibrosis newborn screening. The reference analytical performances and the relatively low cost of ICP-MS, accompanied by the advantageous cost of a single sweat chloride assay, make this technology the best candidate to provide a top reference method for the quantification of chloride in sweat. The method that we propose was optimized and validated for sweat samples ≥ 75 mg, which is the minimum amount requested by the international protocols. However, the method sensitivity and, in addition, the possibility to reduce the sample dilution factor, make possible the quantification of chloride even in samples weighting < 75 mg that are discarded according to the current guidelines. [Figure: see text] Springer Berlin Heidelberg 2020-07-21 2020 /pmc/articles/PMC7495987/ /pubmed/32691087 http://dx.doi.org/10.1007/s00216-020-02821-3 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Research Paper Marvelli, Antonella Campi, Beatrice Mergni, Gianfranco Di Cicco, Maria Elisa Turini, Paola Scardina, Paolo Zucchi, Riccardo Pifferi, Massimo Taccetti, Giovanni Paolicchi, Aldo la Marca, Giancarlo Saba, Alessandro Sweat chloride assay by inductively coupled plasma mass spectrometry: a confirmation test for cystic fibrosis diagnosis |
title | Sweat chloride assay by inductively coupled plasma mass spectrometry: a confirmation test for cystic fibrosis diagnosis |
title_full | Sweat chloride assay by inductively coupled plasma mass spectrometry: a confirmation test for cystic fibrosis diagnosis |
title_fullStr | Sweat chloride assay by inductively coupled plasma mass spectrometry: a confirmation test for cystic fibrosis diagnosis |
title_full_unstemmed | Sweat chloride assay by inductively coupled plasma mass spectrometry: a confirmation test for cystic fibrosis diagnosis |
title_short | Sweat chloride assay by inductively coupled plasma mass spectrometry: a confirmation test for cystic fibrosis diagnosis |
title_sort | sweat chloride assay by inductively coupled plasma mass spectrometry: a confirmation test for cystic fibrosis diagnosis |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7495987/ https://www.ncbi.nlm.nih.gov/pubmed/32691087 http://dx.doi.org/10.1007/s00216-020-02821-3 |
work_keys_str_mv | AT marvelliantonella sweatchlorideassaybyinductivelycoupledplasmamassspectrometryaconfirmationtestforcysticfibrosisdiagnosis AT campibeatrice sweatchlorideassaybyinductivelycoupledplasmamassspectrometryaconfirmationtestforcysticfibrosisdiagnosis AT mergnigianfranco sweatchlorideassaybyinductivelycoupledplasmamassspectrometryaconfirmationtestforcysticfibrosisdiagnosis AT diciccomariaelisa sweatchlorideassaybyinductivelycoupledplasmamassspectrometryaconfirmationtestforcysticfibrosisdiagnosis AT turinipaola sweatchlorideassaybyinductivelycoupledplasmamassspectrometryaconfirmationtestforcysticfibrosisdiagnosis AT scardinapaolo sweatchlorideassaybyinductivelycoupledplasmamassspectrometryaconfirmationtestforcysticfibrosisdiagnosis AT zucchiriccardo sweatchlorideassaybyinductivelycoupledplasmamassspectrometryaconfirmationtestforcysticfibrosisdiagnosis AT pifferimassimo sweatchlorideassaybyinductivelycoupledplasmamassspectrometryaconfirmationtestforcysticfibrosisdiagnosis AT taccettigiovanni sweatchlorideassaybyinductivelycoupledplasmamassspectrometryaconfirmationtestforcysticfibrosisdiagnosis AT paolicchialdo sweatchlorideassaybyinductivelycoupledplasmamassspectrometryaconfirmationtestforcysticfibrosisdiagnosis AT lamarcagiancarlo sweatchlorideassaybyinductivelycoupledplasmamassspectrometryaconfirmationtestforcysticfibrosisdiagnosis AT sabaalessandro sweatchlorideassaybyinductivelycoupledplasmamassspectrometryaconfirmationtestforcysticfibrosisdiagnosis |